NCT05004493
- Conditions
- Antibody-mediated Rejection, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +22 more
- Locations
-
- DeGowin blood Center Iowa City, Iowa, United States
Clinical trial condition
Antibody-mediated Rejection
Explore clinical trials studying Antibody-mediated Rejection. Study availability and eligibility vary by location and protocol.
26 public trials
2 recruiting studies
Antibody-mediated Rejection trial results
NCT06112951
- Conditions
- Antibody-mediated Rejection, Lung Transplant Rejection
- Locations
-
- Medical University of Vienna Vienna, Austria
- UZ Leuven Leuven, Belgium
- University Hospital Center Zagreb Zagreb, Croatia
- Copenhagen University Hospital, Rigshospitalet Copenhagen, Denmark
Not yet recruiting
CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients
NCT07718308
- Conditions
- Antibody-mediated Rejection, Kidney Transplantation
- Locations
-
Not specified
NCT07444489
- Conditions
- Antibody-mediated Rejection, Microvascular Inflammation
- Locations
-
- UCLA College of Medicine Los Angeles, California, United States
- Cooperman Barnabas Medical Center West Orange, New Jersey, United States
- California Pacific Medical Center (Sutter Health) San Francisco, California, United States
- University of Nebraska Medical Center (UNMC) - Nebraska Medicine - Nebraska Medical Center Omaha, Nebraska, United States
Active, not recruiting
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647
- Conditions
- AMR, Antibody-mediated Rejection, Biopsy-proven Histologic Scores, +1 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Scottsdale, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States
Active, not recruiting
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
NCT04561986
- Conditions
- Antibody-mediated Rejection
- Locations
-
- Complejo Hospitalario Universitario A Coruña A Coruña, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Universitario Dr. Peset Valencia, Spain
- Transplant Center, Sahlgrenska University Hospital Gothenburg, Vastra Gotaland Regioin, Sweden
Active, not recruiting
A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
NCT06503731
- Conditions
- Antibody-mediated Rejection
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, not recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
NCT06685757
- Conditions
- Antibody-mediated Rejection
- Locations
-
- University of Southern California Los Angeles, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- Providence Healthcare Orange, California, United States
Active, not recruiting
TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS
NCT07316829
- Conditions
- Antibodies, Donor-Specific, Antibody-mediated Rejection, Bronchial Diseases, +19 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo di Pavia Pavia, Italy
Active, not recruiting
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
NCT03380962
- Conditions
- Antibody-mediated Rejection, Behavior, Chronic Disease, +19 more
- Locations
-
- Norko Ammerman Los Angeles, California, United States